Correlation Between ProMIS Neurosciences and Tff Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProMIS Neurosciences and Tff Pharmaceuticals, you can compare the effects of market volatilities on ProMIS Neurosciences and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Tff Pharmaceuticals.
Diversification Opportunities for ProMIS Neurosciences and Tff Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ProMIS and Tff is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Tff Pharmaceuticals go up and down completely randomly.
Pair Corralation between ProMIS Neurosciences and Tff Pharmaceuticals
Considering the 90-day investment horizon ProMIS Neurosciences is expected to generate 0.26 times more return on investment than Tff Pharmaceuticals. However, ProMIS Neurosciences is 3.87 times less risky than Tff Pharmaceuticals. It trades about -0.29 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.34 per unit of risk. If you would invest 127.00 in ProMIS Neurosciences on September 1, 2024 and sell it today you would lose (33.00) from holding ProMIS Neurosciences or give up 25.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ProMIS Neurosciences vs. Tff Pharmaceuticals
Performance |
| Timeline |
| ProMIS Neurosciences |
| Tff Pharmaceuticals |
ProMIS Neurosciences and Tff Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProMIS Neurosciences and Tff Pharmaceuticals
The main advantage of trading using opposite ProMIS Neurosciences and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.| ProMIS Neurosciences vs. Tff Pharmaceuticals | ProMIS Neurosciences vs. Eliem Therapeutics | ProMIS Neurosciences vs. Inhibrx | ProMIS Neurosciences vs. Enliven Therapeutics |
| Tff Pharmaceuticals vs. Crinetics Pharmaceuticals | Tff Pharmaceuticals vs. Enanta Pharmaceuticals | Tff Pharmaceuticals vs. Amicus Therapeutics | Tff Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |